Marex Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-411
Closed -$218K – 1793
2026
Q2
$218K Sell
411
-431
-51% -$199K ﹤0.01% 978
2026
Q1
$404K Buy
+842
New +$431K ﹤0.01% 681
2024
Q4
– Sell
-811
Closed -$271K – 771
2024
Q3
$271K Buy
+811
New +$308K 0.01% 402

Other funds holding MEDP

Marex Group's MEDP Position: Q3 2026 in Review

Marex Group sold out of Medpace (MEDP) in Q3 2026, closing a stake of 411 shares — an estimated $218K sold.

Marex Group first reported a position in MEDP in Q3 2024 and held it in 3 quarters. The position peaked at $404K in Q1 2026. 755 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Marex Group reported no remaining Medpace position as of Q3 2026 after selling out during the quarter.
  • Marex Group sold 411 Medpace shares in Q3 2026, an estimated $218K.
  • Marex Group first reported a position in Medpace in Q3 2024 and held it in 3 quarters.
  • Marex Group's Medpace position peaked at $404K in Q1 2026.
  • 755 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.